References
- Harris AL. Mutant p53 — the commonest genetic abnormality in human cancer. J Pathol 1990; 162: 5–6
- Levine AJ, Momad J, Finlay CA. The p53 tumor suppressor gene. Nature 1991; 351: 453–456
- Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57: 1083–1093
- Bartek, J, Bartkova, J, Lukas, J, et al. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies. J Pathol 1993; 169: 27–34
- Lane DP. The regulation of p53 function: Steiner Award Lecture. Int J Cancer 1994; 57: 623–627
- Holm, R, Skomedal, H, Helland, A, et al. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant and malignant tissues of the cervix uteri. J Path 1993; 169: 21–26
- Bosari, S, Roncalli, M, Viale, G, et al. p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix. J Path 1993; 169: 425–430
- Teh M, Lee YS. An immunohistochemical study of p53 protein in the different histological subtypes of gastric carcinoma. Pathology 1994; 26: 432–434
- Scheffner, M, Munger, K, Byrne, JC, et al. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci 1991; 88: 5523–5527
- Crook, T, Wrede, D, Tidy, JA, et al. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumors. Lancet 1992; 339: 1070–1073
- Van den Brule, AJC, Snijders, PJF, Gordijin, RLJ, et al. General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int J Cancer 1990; 45: 644–649